EXPRESSION MANUFACTURING Trademark

Trademark Overview

On Thursday, October 15, 2020, a trademark application was filed for EXPRESSION MANUFACTURING with the United States Patent and Trademark Office. The USPTO has given the EXPRESSION MANUFACTURING trademark a serial number of 90257453. The federal status of this trademark filing is REGISTERED as of Tuesday, April 9, 2024. This trademark is owned by Expression Therapeutics LLC. The EXPRESSION MANUFACTURING trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Manufacturing services for others in the field of biotechnology, namely, reagents, cells, vectors, proteins, peptides, antibodies, for use in scientific research, pharmaceutical research, and for clinical and commercial use
expression manufacturing

General Information

Serial Number90257453
Word MarkEXPRESSION MANUFACTURING
Filing DateThursday, October 15, 2020
Status700 - REGISTERED
Status DateTuesday, April 9, 2024
Registration Number7355832
Registration DateTuesday, April 9, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Goods and ServicesManufacturing services for others in the field of biotechnology, namely, reagents, cells, vectors, proteins, peptides, antibodies, for use in scientific research, pharmaceutical research, and for clinical and commercial use
In Another Form StatementThe mark was first used anywhere in a different form other than that sought to be registered at least as early as 11/21/2005
In Another Form StatementThe mark was first used in commerce in a different form other than that sought to be registered at least as early as 10/01/2006
Section 2(f) Limitation StatementAs to "expression"
Disclaimer with Predetermined Text"MANUFACTURING"

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, December 3, 2020
Primary Code040
First Use Anywhere DateThursday, July 1, 2021
First Use In Commerce DateWednesday, June 15, 2022

Trademark Owner History

Party NameExpression Therapeutics LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressTucker, GA 30084
Party NameExpression Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressTucker, GA 30084
Party NameExpression Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressTucker, GA 30084

Trademark Events

Event DateEvent Description
Tuesday, April 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, March 8, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, March 7, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 31, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 31, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 31, 2024ASSIGNED TO LIE
Tuesday, May 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 30, 2022NON-FINAL ACTION E-MAILED
Wednesday, November 30, 2022SU - NON-FINAL ACTION - WRITTEN
Monday, October 31, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 31, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 27, 2022NOTICE OF REVIVAL - E-MAILED
Thursday, October 27, 2022PETITION GRANTED - RESPONSE RECEIVED
Wednesday, October 26, 2022ASSIGNED TO PETITION STAFF
Tuesday, October 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 11, 2022TEAS PETITION TO REVIVE RECEIVED
Monday, September 26, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, September 26, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, March 11, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 11, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 11, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 8, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, March 8, 2022FINAL REFUSAL E-MAILED
Tuesday, March 8, 2022SU - FINAL REFUSAL - WRITTEN
Monday, February 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 3, 2022ASSIGNED TO LIE
Tuesday, February 1, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, January 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, January 30, 2022NON-FINAL ACTION E-MAILED
Sunday, January 30, 2022SU - NON-FINAL ACTION - WRITTEN
Thursday, December 30, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 7, 2021USE AMENDMENT FILED
Thursday, December 30, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 7, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 15, 2021ASSIGNED TO EXAMINER
Thursday, December 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 19, 2020NEW APPLICATION ENTERED

Related Keywords

manufacturing expression research scientific peptides antibodies pharmaceutical commercial clinical proteins vectors field